Literature DB >> 27846193

Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study.

Zoann Nugent1, Harminder Singh, Laura E Targownik, Trevor Strome, Carolyn Snider, Charles N Bernstein.   

Abstract

BACKGROUND: To describe the patterns and predictors of emergency department (ED) attendance and post-ED hospitalization by persons with inflammatory bowel disease (IBD).
METHODS: We linked the University of Manitoba IBD Epidemiology Database with the Emergency Department Information System of the Winnipeg Regional Health Authority to determine the rates of presentation to the ED by persons with IBD from January 01, 2009 to March 31, 2012. Incident cases were diagnosed during the study period and all others were considered prevalent cases. Multivariate logistic regression was used to determine predictors of attendance in the ED and for hospitalization within 2 days of ED attendance.
RESULTS: The study population included 300 incident and 3394 prevalent IBD cases, of whom 76% and 49%, respectively, attended the ED at least once during the study period. Incident cases with Crohn's disease or with a history of opioid use were more likely to attend the ED. Those who had seen a gastroenterologist within the year before diagnosis were less likely to visit the ED. Among prevalent cases, higher comorbidity, opioid or corticosteroid use, and recent hospital admission were predictive of ED attendance and those who saw only 1 physician in the preceding year had lower ED attendance. Presenting to the ED with a primary gastrointestinal complaint was the strongest predictor of subsequent hospital admission.
CONCLUSIONS: ED attendance by both incident and prevalent cases of IBD is high. Identified predictors of ED attendance and post-ED hospitalization could guide the optimization of outpatient IBD care to limit ED attendance and potentially post-ED hospitalization.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27846193     DOI: 10.1097/MIB.0000000000000965

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  13 in total

1.  Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home.

Authors:  Miguel Regueiro; Benjamin Click; Alyce Anderson; William Shrank; Jane Kogan; Sandra McAnallen; Eva Szigethy
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-12       Impact factor: 11.382

2.  Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

Authors:  S Ballou; W Hirsch; P Singh; V Rangan; J Nee; J Iturrino; T Sommers; J Zubiago; N Sengupta; A Bollom; M Jones; A C Moss; S N Flier; A S Cheifetz; A Lembo
Journal:  Aliment Pharmacol Ther       Date:  2018-02-07       Impact factor: 8.171

3.  Chronic opioid use is associated with early biologic discontinuation in inflammatory bowel disease.

Authors:  Christian Rhudy; Courtney L Perry; Michael Singleton; Jeffery Talbert; Terrence A Barrett
Journal:  Aliment Pharmacol Ther       Date:  2021-01-26       Impact factor: 8.171

4.  Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study.

Authors:  Eric I Benchimol; M Ellen Kuenzig; Charles N Bernstein; Geoffrey C Nguyen; Astrid Guttmann; Jennifer L Jones; Beth K Potter; Laura E Targownik; Christina A Catley; Zoann J Nugent; Divine Tanyingoh; Nassim Mojaverian; Fox E Underwood; Shabnaz Siddiq; Anthony R Otley; Alain Bitton; Matthew W Carroll; Jennifer C deBruyn; Trevor Jb Dummer; Wael El-Matary; Anne M Griffiths; Kevan Jacobson; Desmond Leddin; Lisa M Lix; David R Mack; Sanjay K Murthy; Juan Nicolás Peña-Sánchez; Harminder Singh; Gilaad G Kaplan
Journal:  Clin Epidemiol       Date:  2018-11-08       Impact factor: 4.790

5.  The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.

Authors:  M Ellen Kuenzig; Eric I Benchimol; Lawrence Lee; Laura E Targownik; Harminder Singh; Gilaad G Kaplan; Charles N Bernstein; Alain Bitton; Geoffrey C Nguyen; Kate Lee; Jane Cooke-Lauder; Sanjay K Murthy
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

6.  Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.

Authors:  Gunn Huh; Hyuk Yoon; Yoon Jin Choi; Cheol Min Shin; Young Soo Park; Nayoung Kim; Dong Ho Lee; Joo Sung Kim
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

7.  Population Management: A Tool to Improve Timely Care in Pediatric and Young Adult Patients with Inflammatory Bowel Disease.

Authors:  Erealda Prendaj; Sharon Thomas; Gitit Tomer
Journal:  Gastroenterol Res Pract       Date:  2019-07-18       Impact factor: 2.260

8.  Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study.

Authors:  Jingzhou Wang; Takahiro I Nakamura; Anne G Tuskey; Brian W Behm
Journal:  Intest Res       Date:  2019-10-14

9.  The Cost of Use of the Emergency Department by Persons With Inflammatory Bowel Disease Living in a Canadian Health Region: A Retrospective Population-Based Study.

Authors:  Charles N Bernstein; Zoann Nugent; Laura E Targownik; Harminder Singh; Carolyn Snider; Julia Witt
Journal:  J Can Assoc Gastroenterol       Date:  2019-02-19

Review 10.  Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?

Authors:  Matthew Strohl; Lorant Gonczi; Zsuzsanna Kurt; Talat Bessissow; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2018-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.